1. Gas Chromatography–Mass Spectrometry-Based Cerebrospinal Fluid Metabolomics to Reveal the Protection of Coptisine against Transient Focal Cerebral Ischemia–Reperfusion Injury via Anti-Inflammation and Antioxidant
   Junjie Zhang et al, 2023, Molecules CrossRef
2. Tranilast alleviates visceral hypersensitivity and colonic hyperpermeability by suppressing NLRP3 inflammasome activation in irritable bowel syndrome rat models
   Tsukasa Nozu et al, 2024, International Immunopharmacology CrossRef
3. An integrating strategy for systematic profiling of Chinese patent drug’s chemicalome and associated metabolome: Huanghou antidiarrhea dropping pills as a case study
   Li Li et al, 2024, Journal of Chromatography B CrossRef
4. The role of Nrf2 signaling in parasitic diseases and its therapeutic potential
   Mohammadamin Vatankhah et al, 2024, Heliyon CrossRef
5. Coptisine, the Characteristic Constituent from Coptis chinensis, Exhibits Significant Therapeutic Potential in Treating Cancers, Metabolic and Inflammatory Diseases
   Qiang Lu et al, 2023, The American Journal of Chinese Medicine CrossRef
6. Chang-Kang-Fang alleviates diarrhea predominant irritable bowel syndrome (IBS-D) through inhibiting TLR4/NF-κB/NLRP3 pathway
   Sihao Zhang et al, 2024, Journal of Ethnopharmacology CrossRef
7. Coptisine alleviates colitis through modulating gut microbiota and inhibiting TXNIP/NLRP3 inflammasome
   Cailan Li et al, 2024, Journal of Ethnopharmacology CrossRef